Holen Sie sich die Stockscreener-App
105.74
0.62%
0.65
Vorhandelsmarkt:
104.85
-0.89
-0.84%
Nuvalent Inc Aktie (NUVL) Neueste Nachrichten
Nuvalent appoints Ron Squarer to board of directors - Investing.com
Nuvalent Insider Sold Shares Worth $781,537, According to a Recent SEC Filing - marketscreener.com
Ron Squarer Joins Nuvalent Board as Independent Director - TipRanks
Nuvalent appoints Ron Squarer to board of directors By Investing.com - Investing.com Canada
Nuvalent, Inc. Announces Board Changes - marketscreener.com
Nuvalent (Nasdaq: NUVL) taps Ron Squarer for board as zidesamtinib launch prep builds - Stock Titan
Nuvalent Appoints Ron Squarer to Board of Directors - PR Newswire
Nuvalent’s Clinical and Financial Momentum Captivates Investors - Ad-hoc-news.de
Nuvalent, Inc. (NUVL) is a Buy On lung Cancer Treatment Prospects - Insider Monkey
Nuvalent, Inc. (NUVL) is a buy on lung cancer treatment prospects - MSN
Norges Bank Buys Shares of 374,597 Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Nuvalent (NUVL) Price Target Increased by 11.46% to 142.80 - Nasdaq
Affinity Asset Advisors LLC Reduces Position in Nuvalent, Inc. $NUVL - MarketBeat
Russell Investments Group Ltd. Sells 28,747 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Rhumbline Advisers Has $5.04 Million Stock Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Layoff Watch: Is Nuvalent Inc stock trading at a premium valuationEarnings Growth Summary & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
NUVL: Late-stage oncology assets show strong efficacy and safety, with first approvals targeted for 2026 - TradingView
Will Nuvalent Inc. stock attract more institutional investorsMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Nuvalent Insider Sold Shares Worth $434,319, According to a Recent SEC Filing - marketscreener.com
Nuvalent Chief Development Officer Sells Shares - TradingView
Officer Noci Sells 4,000 ($434.3K) Of Nuvalent Inc [NUVL] - TradingView
Nuvalent (NUVL) Stock Analysis Report | Financials & Insights - Benzinga
American Century Companies Inc. Boosts Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Creative Planning Buys 9,079 Shares of Nuvalent, Inc. $NUVL - MarketBeat
(NUVL) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Returns Recap: Is Nuvalent Inc. stock trading near support levelsJuly 2025 Volume & Long Hold Capital Preservation Tips - BỘ NỘI VỤ
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress
Nuvalent (NASDAQ:NUVL) Director Sells $639,814.50 in Stock - MarketBeat
Does Nuvalent’s Recent Trial Success Justify the Stock’s 36% 2025 Rally? - Yahoo Finance
Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Nuvalent Director and 10% Owner Matthew Shair Sells 7,500 Shares - TradingView
Nuvalent to Participate in the Piper Sandler 37th Annual Healthc - GuruFocus
Nuvalent: Deerfield funds sell $70.8m in NUVL stock By Investing.com - Investing.com South Africa
Nuvalent (NUVL) Receives a New Rating from Truist Financial - The Globe and Mail
Nuvalent (NASDAQ:NUVL) Earns Buy Rating from Analysts at Truist Financial - MarketBeat
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders - Finviz
Nuvalent: Deerfield funds sell $70.8m in NUVL stock - Investing.com
Nuvalent closes $500 million public offering of common stock By Investing.com - Investing.com South Africa
Nuvalent Announces Closing of Public Offering of Common Stock an - GuruFocus
Nuvalent Closes Public Offering of Common Shares - marketscreener.com
Nuvalent closes $500 million public offering of common stock - Investing.com
Nuvalent (NASDAQ: NUVL) closes $500M stock offering; 4,950,496 shares sold in public deal - Stock Titan
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders – Company AnnouncementFT.com - Financial Times
Nuvalent announces public offering of common stock - MSN
FDA accepts NDA for Nuvalent's zidesamtinib for non-small cell lung cancer - MSN
What is Wedbush's Estimate for Nuvalent FY2027 Earnings? - MarketBeat
Intech Investment Management LLC Boosts Stock Position in Nuvalent, Inc. $NUVL - MarketBeat
J.P. Morgan Sticks to Its Buy Rating for Nuvalent (NUVL) - The Globe and Mail
Four companies raise nearly $950M in follow-ons: Public Equity Report - BioCentury
Nuvalent Announces $500M Stock Offering Pricing - The Globe and Mail
Biotech Stock Gets Booted in Latest Fund Update - AOL.com
Will Nuvalent Inc. stock keep outperforming rivalsJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Why analysts upgrade Nuvalent Inc. stockJuly 2025 Weekly Recap & Technical Pattern Based Buy Signals - newser.com
Sidley Represents Nuvalent in Pricing of US$500 Million Public Offering - Legal Desire Media and Insights
Jefferies raises Nuvalent stock price target to $164 on promising cancer drug data - Investing.com Nigeria
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):